SKP2 and glioblastoma: U251 and SNB19 human GBM cells treated with variable curcumin preparations were found to have decreased Skp2 expression via RT-PCR, as well as decreased migration, invasion, and proliferation; viral transfection with Skp2 cDNA rescued growth inhibition by curcumin [36].